Significant evidence implicates interleukin-17 (IL-17) in the pathogenesis of systemic lupus erythematosus (SLE), particularly in the development of tissue damage. IL-17 production and IL-17-producing CD4+ and CD3 + CD4−CD8− cells are increased in patients with SLE. IL-17-producing cells are present in the inflamed kidney tissues from patients with lupus nephritis. In lupus-prone mice, IL-17 production appears to be involved in the expression of disease pathology and pharmacologic or genetic manipulation of its production results in suppression of the disease. It becomes obvious that the use of biologics including humanized anti-IL-17 antibodies or decoy IL-17 receptors deserve clinical consideration. Similarly, the development of drugs that suppress the production of IL-17 is in order.
CrispinJCLiossisSNKis-TothK. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med2010; 16: 47–57.
2.
BalowJE. Clinical presentation and monitoring of lupus nephritis. Lupus2005; 14: 25–30.
3.
Adalid-PeraltaLMathianATranT. Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis. Kidney Int2008; 73: 172–180.
4.
CohenRABaylissGCrispinJC. T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol2008; 128: 1–7.
5.
KornTOukkaMKuchrooVBettelliE. Th17 cells: effector T cells with inflammatory properties. Semin Immunol2007; 19: 362–371.
6.
OuyangWKollsJKZhengY. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity2008; 28: 454–467.
7.
SchwarzenbergerPHuangWYeP. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol2000; 164: 4783–4789.
8.
WitowskiJPawlaczykKBreborowiczA. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol2000; 165: 5814–5821.
9.
RuddyMJShenFSmithJBSharmaAGaffenSL. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol2004; 76: 135–144.
10.
LaanMCuiZHHoshinoH. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol1999; 162: 2347–2352.
11.
AlbanesiCCavaniAGirolomoniG. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol1999; 162: 494–502.
12.
DoreauABelotABastidJ. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol2009; 10: 778–785.
13.
MitsdoerfferMLeeYJagerA. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A2010.
14.
Riol-BlancoLLazarevicVAwasthiA. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J Immunol2010; 184: 1710–1720.
15.
ParkHLiZYangXO. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol2005; 6: 1133–1141.
16.
HarringtonLEHattonRDManganPR. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol2005; 6: 1123–1132.
17.
VeldhoenMHockingRJAtkinsCJLocksleyRMStockingerB. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity2006; 24: 179–189.
18.
YangLAndersonDEBaecher-AllanC. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature2008; 454: 350–352.
19.
ManganPRHarringtonLEO’QuinnDB. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature2006; 441: 231–234.
20.
LangrishCLChenYBlumenscheinWM. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med2005; 201: 233–240.
21.
WongCKHoCYLiEKLamCW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus2000; 9: 589–593.
22.
WongCKLitLCTamLSLiEKWongPTLamCW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol2008; 127: 385–393.
23.
CrispinJCOukkaMBaylissG. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol2008; 181: 8761–8766.
24.
YangJChuYYangX. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum2009; 60: 1472–1483.
25.
Linker-IsraeliMBakkeACKitridouRCGendlerSGillisSHorwitzDA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol1983; 130: 2651–2655.
26.
LaurenceATatoCMDavidsonTS. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity2007; 26: 371–381.
27.
Linker-IsraeliMDeansRJWallaceDJPrehnJOzeri-ChenTKlinenbergJR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol1991; 147: 117–123.
28.
HaradaTKyttarisVLiYJuangYTWangYTsokosGC. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity2007; 40: 1–8.
29.
YangXOPanopoulosADNurievaR. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem2007; 282: 9358–9363.
30.
deBLPuelAFilipe-SantosO. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med2008; 205: 1543–1550.
31.
CohenPLEisenbergRA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol1991; 9: 243–269.
32.
IgarashiSTakiguchiMKariyoneAKanoK. Phenotypic and functional analyses on T-cell subsets in lymph nodes of MRL/Mp-lpr/lpr mice. Int Arch Allergy Appl Immunol1988; 86: 249–255.
33.
ZhangZKyttarisVCTsokosGC. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol2009; 183: 3160–3169.
34.
WangYItoSChinoY. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol2009; 159: 1–10.
35.
KyttarisVCZhangZKuchrooVKOukkaMTsokosGC. IL-23 receptor deficiency prevents the development of lupus nephritis in B6/lpr mice. J Immunol2010; in press.
36.
GhatakSSainisKOwenFLDattaSK. T-cell-receptor beta- and I-A beta-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB × SWR crosses. Proc Natl Acad Sci U S A1987; 84: 6850–6853.
37.
KangHKLiuMDattaSK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol2007; 178: 7849–7858.
38.
KangHKMichaelsMABernerBRDattaSK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol2005; 174: 3247–3255.
39.
WuHYQuintanaFJWeinerHL. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+. J Immunol2008; 181: 6038–6050.
40.
HsuHCZhouTKimH. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum2006; 54: 343–355.
41.
HsuHCYangPWangJ. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol2008; 9: 166–175.
42.
EspinosaADardalhonVBraunerS. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med2009; 206: 1661–1671.
43.
BiswasPSGuptaSChangE. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest2010; 120: 3280–3295.
44.
LiYHaradaTJuangYT. Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J Immunol2007; 178: 1938–1947.
